Dialysable leucocyte extract (DLE) reduces lipopolysaccharide- Induced tumour necrosis factor secretion in human leucocytes

Biotherapy

Volumn 9, Issue 1-3, 1996, Pages 163-170

  Ojeda, Miriam Ojeda ^a   Ortega, Celia B Fernandez ^a   Arana De Rosaïnz, Manuel J ^a  

^a Center for Biological Research Cuba   (Cuba)

Author keywords

Dialysable leucocyte extract; Lipopolysaccharide; Transfer factor; Tumour necrosis factor

Indexed keywords

IMMUNOMODULATING AGENT; LEUKOCYTE EXTRACT; LIPOPOLYSACCHARIDE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; BLOOD; CELL SECRETION; CELL STRAIN L 929; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DIALYSATE; DONOR; DRUG ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATORY DISEASE; LEUKOCYTE; MONOCYTE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL;

ANIMALS; CELL EXTRACTS; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DIALYSIS; FIBROBLASTS; HUMANS; LEUKOCYTES; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; TRANSFER FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029752424     PISSN: 0921299X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02628675     Document Type: Article

References (30)

1. Beautler B & Cerami A. Tumor necrosis, cachexia, shock, and inflammation: A common mediator. Ann R Bioch 1988; 57: 505-18.
2. Kobayashi S, Hamamoto Y, Kobayashi N. et al.Serum level of TNFa in HTV-infected individuals. AIDS 1990; 4:169-70.
3. Gessani S, Testa U, Varano B, Di Marzio P, Borghi P, Conti L, Barber! T, Tritarelli E, Martucci R, Seripa D, Peschle C & Belardelli F. Enhanced production of LPS-induced cytokines during differentiation of human monocytes to macrophages. J Immunol 1993; 151: 3758-66.
4. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Harry RJ, Fahey TJ, Zentella A & Alben JD. Shock and injury induced by recombinant human cachectin. Science 1986; 234: 470.
5. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF & Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330: 662.
6. Hober D, De Groote D, VanpouiUe N, Dehart I, ShenL,Wattre P & Maniez-Montreuil M. Tumor necrosis factor receptor expression in HTV-1 infected CD4+ T cells. Microb Immu 1994; 38 (12): 1005- 12.
7. Lahdevirta J, Maury CPJ, Teppo AM & Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am I Med 1988; 85: 289-91.
8. Stricter RM, Kunkel SL & Bone G. Role of tumor necrosis factor- a in desease states and inflammation. Crit Care M 1993; 21: 447-63.
9. Fudenberg HH & Pizza G. Transferfactor 1993:Newfronùers. In: Tucker E. ed, Progress in Drug Research. Basel: Burkhauser 1994; 42: 309-400.
10. Lokaj J, Pckarek J & Kuklinek P. Dialysable leukocyte extract in the therapy of sepsis. Leukocyte dialysates and transfer factor. Bratislava: Slovak Academy of Science, 1987: 516-25.
11. Aggarwal BB: J Biol Chem 1985; 260: 2345-54.
12. Larrick JW, Hirata M, Zheng H, Zhong J, Bolin D, Cavaillon JM, Warren HS & Wright SC. A novel granulocytederived peptide with lipopolysaccharide-neutralizing activity. J Immunol 1994; 152: 231.
13. Zhong WW, Burke PA, Hand AT, Walsh MJ, Hughes LA & Forse RA. Regulation of cytokine mRNA expression in lipopolysaccharide- stimulated human macrophages. Arch Surg 1993; 128: 158-64.
14. Lynn WA, Liu Y & Golenbock DT. Neither CD14 nor serum is absolutely necessary for activation of mononuclear phagocytes by bacterial lipopolysaccharide. Infec Immun 1993; 61:445261.
15. Lynn WA, Raetz CRH, Qureshi N & Golenbock DT. LPS induced stimulation of CD lib/CD 18 expression on neutrophils: evidence of specific receptor-based response and inhibition by lipid A-based antagonists. I Immunol 1991; 147: 3072-79.
16. Haziot A, Chen S, Ferrero E, Low MG, Silber R & Goyert SM. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinisitol linkage. J Immunol 1988; 141: 547- -52.
17. Wright SD, Ramos RA, Hermanowski-Vosatka AH, Rockwell P & Derniers PA.. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD 14. JExpMed 1991; 173:1281-86.
18. Zuckerman SH, Evans GF, Snyder YM & Roeder WR. Endotoxin- macrophage interactions: post- translational regulation of tumor necrosis factor expression. J Immunol 1989; 143: 1223-27.
19. Hans J, Brown T & Beutler B. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med 1990; 171: 465-75.
20. Dedrick RL & Conlon PJ. Prolonged expression of lipopolysaccharide (LPS)-induced inflammatory genes in whole blood requires continual exposure to LPS. Infec Immun 1995; 63: 1362
21. Zuckerman SH, Evans GF & Gutherie L. Transcriptional and post- translational mechanisms involved in the differential expression of LPS- induced IL-1 and TNF mRNA. Immunology 1991; 73: 460-65.
22. Gallay P, Jongeneel CV, Barras C, Burnier M, Baumgartner JD, Glauser MP & Heumarm D. Short time exposure to lipopolysaccharide is sufficient to activate human monocytes. J Immunol 1993; 150: 5086- 93.
23. Kovacs EJ, Radzioch D, Young HA & Varesio L. Differential inhibition of EL-1 and TNFa mRNA expression by agents which block second messenger pathways in murine macrophages. J Immunol 1988; 141: 3101-5.
24. Gong JH, Renz H, Sprenger H, Nain M & Gemsa D. Enhancement of tumor necrosis factor-a gene expression by low doses of prostaglandin E2 and cyclic GMP. Immunobiol 1990; 182: 44-55.
25. Casey LC, Balk RA & Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Int Med 1993; 119: 771-78.
26. Danner RL, Elin RJ, Mosseini JM, Wesley RA, Reilly JM & Parillo JE.. Endotoxemia in human septic shock. Chest 1991; 99: 169-75.
27. Haziot A, Tsuberi BZ & Goyert SM. Neutrophil CD14:Biochemical properties and role in the secretion of tumor necrosis factor-a in response to lipopolysaccharide. J Immunol 1993; 150: 5556-65.
28. Matsumoto C, Takenouchi K & Sasakawa S. In: Fujisawa T. ed. Recent Advances in Transfer Factor and OLE. 1990: 175-83.
29. Broide DH, Lotz M, Cuomo AJ et al. J Allerg Clin 1992; 89: 958- 967.
30. Poli G, Kinter A, Justement JS. Kehrl JH, Bressler P, Stanley S & Fauci AS. Tumor necrosis factor a functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sei 1990. 87: 782-85.